Protocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic Leukemia

Summary

This research study will look at the effects (good or bad) of administering cyclophosphamide, fludarabine, and rituximab. Clinical studies with combination therapy have shown higher response rates than using single drugs, and this study will evaluate the side effects and effectiveness of this combination.

Timeline

Start

2004-06

Primary completion

2008-02

Completion

2013-01

Drugs

Indications